Emma Furth

10PUBLICATIONS
93CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 11, 2026
Aberrant O-glycosylation Induces IL-34-Mediated Immune Remodeling and Promotes Pancreatic Cancer Progression.

|Aug 10, 2026
Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular Analyses.

|Jul 03, 2026
CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance.

|Mar 12, 2026
Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma.

Minh T Than, Lucie Dequiedt, Rina Sor

|Feb 01, 2026
Despite simplified diagnostic criteria, intraobserver and interobserver variability remain in the interpretation of colorectal serrated polyps.

Adam L Booth, Emina E Torlakovic, Runjan Chetty

|Aug 01, 2025
MRI Detection of PDAC Response to KRAS Inhibitor Therapy-Response.

Rong Zhou, Yong Fan, Emma E Furth

Pageof 2

Frequent Collaborators

3 joint publications

Rong Zhou

3 joint publications

Cynthia Clendenin

3 joint publications

Ben Z Stanger

2 joint publications

Stephen Pickup